XML 13 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Jun. 30, 2018
Current assets    
Cash and cash equivalents $ 3,964,717 $ 7,012,527
Restricted cash 100,148 100,000
Accounts receivable, net 760,056 578,782
Inventory, net 1,310,103 1,338,973
Prepaid expenses and other 736,980 440,009
Total current assets 6,872,004 9,470,291
Fixed assets, net 196,420 218,684
Licensed assets, net 10,674,462 11,120,086
Patents, net 239,611 245,944
Deposits 2,200 5,088
Total long-term assets 11,112,693 11,589,802
Total assets 17,984,697 21,060,093
Current liabilities    
Accounts payable and other 2,111,783 2,119,672
Accrued liabilities 428,851 185,882
Accrued compensation 796,848 540,674
Current deferred rent 1,450
Current contingent consideration 249,631 547,100
Total current liabilities 3,587,113 3,394,778
Long-term contingent consideration 4,220,819 4,146,829
Warrant derivative liability 46,629 93,981
Total liabilities 7,854,561 7,635,588
Commitments and contingencies (Note 7)
Stockholders' equity    
Preferred Stock, par value $.0001; 50,000,000 shares authorized; shares issued and outstanding 0 and 0, respectively as of September 30, 2018 (unaudited) and June 30, 2018
Common Stock, par value $.0001; 100,000,000 shares authorized; shares issued and outstanding 1,801,411 (unaudited) and 1,794,762, respectively as of September 30, 2018 and June 30, 2018 180 179
Additional paid-in capital 92,834,031 92,681,918
Accumulated deficit (82,704,075) (79,257,592)
Total stockholders' equity 10,130,136 13,424,505
Total liabilities and stockholders' equity $ 17,984,697 $ 21,060,093